-
Comparative Outcomes of Neo-Adjuvant Chemo-Radiotherapy in Stage II and III Mucinous versus Non-Mucinous Rectal Adenocarcinoma: A Retrospective Study
30 Oct 2025 05:21 GMT
… and Aggressiveness of MAC
Mucinous adenocarcinoma (MAC) exhibits distinct … evidence that mucinous rectal adenocarcinoma has distinct pathological characteristics … adjuvant chemotherapy in mucinous colorectal adenocarcinoma without distant metastasis. Cancers …
-
<![CDATA[VS-7375 Shows Early Promise Against KRAS G12 Mutant Solid Tumors]]>
02 Nov 2025 03:47 GMT
… in KRAS G12D-mutated pancreatic adenocarcinoma (PDAC), highlighting the critical unmet …
-
<![CDATA[Vaccines in Cancer Care: Evidence, Guidelines & Clinical Considerations]]>
02 Nov 2025 00:26 GMT
… multiple cancer types, including gastric adenocarcinoma, breast, lung, gynecologic, colorectal and …
-
<![CDATA[Novel Intratumoral Formulation Shows Responses/Safety in Metastatic Cancers]]>
01 Nov 2025 23:11 GMT
… (9.4%), colorectal adenocarcinoma (9.4%), breast adenocarcinoma (6.3%), and ovarian … adenocarcinoma (6.3%).
The primary …
-
Stomach Cancer: 5 Morning Symptoms You Shouldn’t Ignore
01 Nov 2025 22:11 GMT
… stomach. The most common form, adenocarcinoma, originates in the stomach’s …
-
Weiner Lab Explores Novel Cancer Immunotherapies
01 Nov 2025 22:05 GMT
… and cytotoxicity in pancreatic ductal adenocarcinoma models.”
Weiner said this approach …
-
<![CDATA[Personalized, Patient-Centered Strategies Shape the Evolving Management of Metastatic Pancreatic Cancer]]>
01 Nov 2025 18:52 GMT
… -line treatment of metastatic pancreatic adenocarcinoma. FDA. February 13, 2024. Accessed … -first-line-treatment-metastatic-pancreatic-adenocarcinoma
Dotan E, Catalano PJ, Lenchik …
-
DESTINY-Lung06 phase 3 trial of Enhertu initiated as first-line therapy in patients with HER2 overexpressing metastatic non-squamous NSCLC
01 Nov 2025 18:41 GMT
… +) gastric or gastroesophageal junction (GEJ) adenocarcinoma who have received a prior …
-
One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it
01 Nov 2025 18:30 GMT
… undergone surgery for pancreatic ductal adenocarcinoma (PDAC), the most common form …
-
NCC-Bio and GR Boston N. Announce Breakthrough in Overcoming KRAS Therapy Resistance, Pancreatic Cancer Awareness Month
01 Nov 2025 04:00 GMT
… clinical trial in pancreatic ductal adenocarcinoma (PDAC) is expected to begin …